NXI Therapeutics AG
Biotechnology Research
10.094, Ch
5 employees
- Employees
- 5
- Contacts
- 2
- Emails
- 2
NXI Therapeutics AG Overview
- Headquarters
- 10.094, Ch
- Website
- www.nxitherapeutics.com
- Industry
- Biotechnology Research
- Employees
- 5
- Founded
- 2021
- Funding
- 4.0M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About NXI Therapeutics AG
NXI therapeutics focuses on the research and development of a new generation of selective immunosuppressive drugs for autoimmune diseases and transplantations - with objectives of high efficacy, good safety without adverse effects as seen with conventional immunosuppressants.
NXI Therapeutics AG Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
NXI Therapeutics AG Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Rajesh Jayachandran, Md Phd | Chief Scientific Officer, Nxi | Basel, Switzerland |
View
|
| Ruben Herrendorff | CEO at Nxi Therapeutics | Basel, Switzerland |
Email
|
| Reto Erni | Nxi Therapeutics Ag/university of Basel |
View
|
|
| Zoltan Czigler | Zug, Switzerland |
Email
|
Employees by Management Level
Executive
2 profiles
Individual contributor
1 profile
Compare Similar Companies to NXI Therapeutics AG
Rege Nephro Co., Ltd.
Biotechnology Research
Synendos Therapeutics AG
Pharmaceutical Manufacturing
ClexBio
Biotechnology
Biospectal SA
Medical Equipment Manufacturing
Cellestia Biotech
Biotechnology Research
Ymmunobio
Biotechnology Research
Aukera Therapeutics
Biotechnology Research
Tandem Therapeutics
Biotechnology Research
Regenosca SA
Medical Equipment Manufacturing
Allegria Therapeutics
Biotechnology Research